Kirkland & Ellis LLP

The team at Kirkland & Ellis LLP handles complex disputes involving alleged personal injury and economic loss arising from drug and medical device products. The practice represents manufacturers in putative class actions and MDLs, with experience addressing failure-to-warn allegations, product labeling and disclosure issues, and claims tied to marketing and pricing practices. James Hurst, based in Chicago, focuses on matters involving alleged gastrointestinal injuries, including claims concerning infant formula, GLP-1 medications, and HIV drugs, as well as allegations of delayed introduction of alternative therapies. In New York, Jay Lefkowitz concentrates on prescription and over-the-counter drug litigation involving alleged mislabeling, ingredient disclosures, and marketing conduct, including claims asserting links between acne treatments and cancer. Allison Brown, based in Philadelphia, brings experience across MDLs involving both personal injury and economic loss, while Kim Bueno, based in Austin, serves as trial counsel in medical device litigation, including pelvic mesh matters. Mike Brock, based in Washington DC, is also a key member of the team, contributing to the team’s work in this area.